drugset / Trial / NCT00418145
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Phase 3
Terminated
16 enrolled
Fred Lublin
National Multiple Sclerosis Society · collabPfizer · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical trial compares the relative efficacy of treating acute exacerbations of relapsing forms of Multiple Sclerosis with equivalent doses of oral and intravenous (IV) methylprednisolone. This is a randomized, blinded, multi-center study.
Timeline
- Start
- 2003-09
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 1000 mg | Oral |
| Subject | Methylprednisolone | Other / unclassified | 1400 mg | Oral |